The risk of missed gastroesophageal cancer diagnoses in users and nonusers of antisecretory medication

Gastroenterology

Volumn 129, Issue 4, 2005, Pages 1179-1186

  Lassen, Annmarie ^a   Hallas, Jesper ^b   Schaffalitzky De Muckadell, Ove B ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOSCOPY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GASTROESOPHAGEAL CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER;

EID: 26844571824     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.07.028     Document Type: Article

References (25)

1. H.M. Sue-Ling, D. Johnston, I.G. Martin, M.F. Dixon, M.R. Lansdown, M.J. McMahon, A.T. Axon Gastric cancer a curable disease in Britain BMJ 307 1993 591 596
2. D.J. Bowrey, G.W. Clark, B.I. Rees, G.T. Williams, P.D. Carey Outcome of oesophagogastric carcinoma in young patients Postgrad Med J 75 1999 22 26
3. D.A. Corley, T.R. Levin, L.A. Habel, N.S. Weiss, P.A. Buffler Surveillance and survival in Barrett's adenocarcinomas a population-based study Gastroenterology 122 2002 633 640
4. J.L. Whiting, A. Sigurdsson, D.C. Rowlands, M.T. Hallissey, J.W. Fielding The long term results of endoscopic surveillance of premalignant gastric lesions Gut 50 2002 378 381
5. J. Christie, N.A. Shepherd, B.W. Codling, R.M. Valori Gastric cancer below the age of 55 implications for screening patients with uncomplicated dyspepsia Gut 41 1997 513 517
6. C. Canga III, N. Vakil Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy Am J Gastroenterol 97 2002 600 603
7. I.G. Martin, S. Young, H. Sue-Ling, D. Johnston Delays in the diagnosis of oesophagogastric cancer a consecutive case series BMJ 314 1997 467 470
8. S.J. Panter, H. O'Flanagan, M.G. Bramble, A.P. Hungin Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcome Aliment Pharmacol Ther 19 2004 981 988
9. N.J. Talley, M.D. Silverstein, L. Agreus, O. Nyren, A. Sonnenberg, G. Holtmann American Gastroenterological Association AGA technical review evaluation of dyspepsia Gastroenterology 114 1998 582 595
10. M.T. Hallissey, W.H. Allum, A.J. Jewkes, D.J. Ellis, J.W. Fielding Early detection of gastric cancer BMJ 301 1990 513 515
11. J. Wayman, N. Hayes, S.M. Griffin The response of early gastric cancer to proton-pump inhibitors N Engl J Med 338 1998 1924 1925
12. J. Wayman, N. Hayes, S.A. Raimes, S.M. Griffin Prescription of proton pump inhibitors before endoscopy. A potential cause of missed diagnosis of early gastric cancers Arch Fam Med 9 2000 385 388
13. M.G. Bramble, Z. Suvakovic, A.P. Hungin Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy Gut 46 2000 464 467
14. L. Frank Epidemiology. When an entire country is a cohort Science 287 2000 2398 2399
15. H.H. Storm, E.V. Michelsen, I.H. Clemmensen, J. Pihl The Danish Cancer Registry - history, content, quality and use Dan Med Bull 44 1997 535 539
16. T.F. Andersen, M. Madsen, J. Jorgensen, L. Mellemkjoer, J.H. Olsen The Danish National Hospital Register. A valuable source of data for modern health sciences Dan Med Bull 46 1999 263 268
17. D. Gaist, H.T. Sorensen, J. Hallas The Danish prescription registries Dan Med Bull 44 1997 445 448
18. Classification index including defined daily doses (DDD) for plain substances 1995 WHO Collaborating Centre for Drug Statistical Methodology Oslo, Norway
19. Cancer incidence in Denmark 1999 2004 National Board of Health, Health Statistics Copenhagen, Denmark
20. H.S. Lau, A. de-Boer, K.S. Beuning, A. Porsius Validation of pharmacy records in drug exposure assessment J Clin Epidemiol 50 1997 619 625
21. Z. Suvakovic, M.G. Bramble, R. Jones, C. Wilson, N. Idle, J. Ryott Improving the detection rate of early gastric cancer requires more than open access gastroscopy a five year study Gut 41 1997 308 313
22. N.P. Breslin, A.B. Thomson, R.J. Bailey, P.K. Blustein, J. Meddings, E. Lalor, G.M. VanRosendaal, M.J. Verhoef, L.R. Sutherland Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia Gut 46 2000 93 97
23. D.C. Farrow, T.L. Vaughan, C. Sweeney, M.D. Gammon, W.H. Chow, H.A. Risch, J.L. Stanford, P.D. Hansten, S.T. Mayne, J.B. Schoenberg, H. Rotterdam, H. Ahsan, A.B. West, R. Dubrow, J.F. Fraumeni Jr, W.J. Blot Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer Cancer Causes Control 11 2000 231 238
24. A. Lassen, J. Hallas, O.B. Schaffalitzky de Muckadell Use of anti-secretory medication a population-based cohort study Aliment Pharmacol Ther 20 2004 577 583
25. P. Bytzer, P.B. Christensen, P. Damkier, K. Vinding, N. Seersholm Adenocarcinoma of the esophagus and Barrett's esophagus a population-based study Am J Gastroenterol 94 1999 86 91